Brindavana Naga Gopal Palepu

Brindavana Naga Gopal Palepu

Active Director Director DIN 00850603
DIN 00850603 First appointment May 2002 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since May 2002
Shareholding value •••• Premium profile

About Brindavana Naga Gopal Palepu

Data last updated:

Brindavana Naga Gopal Palepu is a Director at Axon Anaesthesia Associates Private Limited (since 2002) and Director at Gaman Health Care Private Limited (since 2011). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹48.48 Cr; the largest is Axon Anaesthesia Associates Private Limited at ₹46.17 Cr (FY 2025). Earlier, Brindavana Naga Gopal Palepu was a Designated Partner at Swast Critical Care Services Llp (2020–2023) and Director at Axon International Medicare Academy Private Limited (from 2013).

DIN 00850603
Primary Designation Director
Industry Healthcare
First Appointment 07 May 2002
Oldest Company Age 24 yrs
Largest company Axon Anaesthesia Associates Private Limited · ₹46.17 Cr (FY 2025)
Combined revenue ₹48.48 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 May 20022002₹46.17 Cr (FY 2025)Active
Gaman Health Care Private Limited U85110TG2011PTC077318
Director09 Nov 20112011₹2.31 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Oct 20202020Active
Director25 Jun 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Gaman Health Care Private Limited
Axon International Medicare Academy Private Limited
Axon Anaesthesia Associates Private Limited
Swast Critical Care Services Llp
Premium access

Shareholding and investment profile for Brindavana Naga Gopal Palepu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Brindavana Naga Gopal Palepu

Brindavana Naga Gopal Palepu currently holds 2 directorships: Axon Anaesthesia Associates Private Limited (Director, since 07 May 2002, revenue ₹46.17 Cr (FY 2025)); Gaman Health Care Private Limited (Director, since 09 Nov 2011, revenue ₹2.31 Cr (FY 2024)).

Brindavana Naga Gopal Palepu was first appointed on 07 May 2002 as Director at Axon Anaesthesia Associates Private Limited. The most recent appointment on record is 12 Oct 2020 at Swast Critical Care Services Llp.

The 2 current companies of Brindavana Naga Gopal Palepu that report revenue have a combined latest revenue of ₹48.48 Cr: Axon Anaesthesia Associates Private Limited ₹46.17 Cr (FY 2025); Gaman Health Care Private Limited ₹2.31 Cr (FY 2024).

Brindavana Naga Gopal Palepu held 2 earlier board appointments: Swast Critical Care Services Llp (Designated Partner, 12 Oct 2020 to 19 Aug 2023); Axon International Medicare Academy Private Limited (Director, from 25 Jun 2013).

The current boards of Brindavana Naga Gopal Palepu's companies include Krishna Prasad Mulavisala (Axon Anaesthesia Associates Private Limited), Mohammed Saadat Ali Khan (Axon Anaesthesia Associates Private Limited), Ravi Chandra Raya Srinivasa (Axon Anaesthesia Associates Private Limited), Subrahmanyam Maddirala (Axon Anaesthesia Associates Private Limited), Surjya Kanta Mohanty (Axon Anaesthesia Associates Private Limited), Venkata Sanjeev Gopal Thota (Axon Anaesthesia Associates Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available